Skip to main navigation Skip to search Skip to main content

Frequency-domain fluorescence-enhanced optical tomography for primary prostate cancer with PET validation in siemens inveon scanner: A reliminary result

  • Yujie Lu
  • , I. Chih Tan
  • , Chinmay Darne
  • , Nathaniel Wilganowski
  • , Holly Robinson
  • , John Rasmussen
  • , Shikui Yan
  • , Anne M. Smith
  • , Eva M. Sevick-Muraca

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Abstract

With a dual-labeled imaging agent, Optical/CT/PET primary prostate cancer imaging was performed in a Siemens Inveon scanner. PET-based imaging validation shows the potential of the developed fluorescence tomography for preclinical research.

Original languageEnglish (US)
Title of host publicationBiomedical Optics, BIOMED 2012
PagesBTu4A.4
StatePublished - 2012
EventBiomedical Optics, BIOMED 2012 - Miami, FL, United States
Duration: Apr 28 2012 → May 2 2012

Publication series

NameBiomedical Optics, BIOMED 2012

Other

OtherBiomedical Optics, BIOMED 2012
Country/TerritoryUnited States
CityMiami, FL
Period4/28/12 → 5/2/12

ASJC Scopus subject areas

  • Biotechnology
  • Atomic and Molecular Physics, and Optics

Fingerprint

Dive into the research topics of 'Frequency-domain fluorescence-enhanced optical tomography for primary prostate cancer with PET validation in siemens inveon scanner: A reliminary result'. Together they form a unique fingerprint.

Cite this